Skip to main content
All lobbying filings

THE WASHINGTON TAX & PUBLIC POLICY GROUP

Lobbying for ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION · Biopharmaceutical industry

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $500,000.00 income · posted Apr 1, 2026

Official filing document

 Lobbying activity 1
Taxation/Internal Revenue Code

Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations and agreements on the taxation of global income and the potential impacts on financial reporting and on the tax base of the U.S. and its Territories. Issues related to the taxation of intellectual property income. Issues related to IRC sections 11, 41 and 174, 55, 56A, and 59, 59A, 163(j), 250, 951A.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem